DYAI
Dyadic International, Inc.
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Dyadic International (DYAI) Stock: Buy, Sell, or Hold?
$0.35
-0.04 (-9.77%)
▼
5d:
+2.94%
30d:
-14.65%
90d:
-54.83%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (86%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$0.36 – $0.43
Position: OVERSOLD
Forward P/E & Valuation
15.0x
CHEAP
vs 35.2x historical avg
Wall Street Target
$5.50
+1471.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.33 / $0.41
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: DYAI shows positive signals but monitor for confirmation. Market pricing in 24.7% decline. Moderate conviction.
Get Alerted When DYAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: DYAI is currently trading at $0.35, which is considered oversold relative to its 30-day fair value range of $0.36 to $0.43. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.0) compared to its historical average (35.2). Remarkably, the market is currently pricing in an annual earnings decline of 24.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DYAI is in a strong downtrend. Immediate support is located at $0.33, while resistance sits at $0.41. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: DYAI scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+1471.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DYAI is in a strong downtrend. Immediate support is located at $0.33, while resistance sits at $0.41. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: DYAI scores 69/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $5.50 (+1471.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.36 -
$0.43
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
Trading Range & Key Levels
30-Day Trading Range
$0.36 -
$0.43
Current vs Trading Range
OVERSOLD
Support Level
$0.33
Resistance Level
$0.41
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (69/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.8%)
- BULLISH: Trading 1471.0% below Wall St target ($5.50)
- BULLISH: Bottoming setup score 69/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
15.03
Wall Street Target
$5.50
(+1471.0%)
Revenue Growth (YoY)
-0.6%
Profit Margin
-200.5%
Valuation Discount vs History
-24.7% cheaper
PE vs Historical
15.0 vs 35.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.7%
(market-implied from PE analysis)
1-Year Target
$0.32
(-10%)
2-Year Target
$0.28
(-19%)
3-Year Target
$0.26
(-27%)
3-Yr Target (if PE normalizes)
(PE: 15→35)
$0.60
(+71%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.0 to 35.2
Stabilization Target:
$0.82
(+134.3%)
PE Expansion Potential:
+134.3%
Share DYAI Analysis
Share this live DYAI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DYAI)
Bullish
4 Retail Mentions
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Dyadic Applied BioSolutions ($DYAI) announced a strategic collaboration with BRIG BIO and Strive Nutrition to commercialize precision-fermented Alpha-Lactalbumin in premium nutrition markets.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:26 PM ET
Data refreshes hourly during market hours. Next update: 8:26 PM
Data refreshes hourly during market hours. Next update: 8:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DYAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DYAI Research Pages
